IGC Pharma Profit Margin

The latest profit margin for IGC is -702.14% as of June 2026. That compares with -477.92% in the prior-year period — down 46.9% year over year. That is below the Healthcare sector average of 13.89%. Investors often review this figure alongside IGC Pharma's historical trend and sector peers before judging valuation or financial health.

Over the past year, IGC's profit margin moved from -477.92% to -702.14% — a 46.9% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in IGC Pharma's valuation or profitability profile.

Against Healthcare companies, IGC currently prints -702.14% for profit margin, while the sector average sits near 13.89%. That is roughly 5156.8% below the sector mean. Large gaps often invite a closer look at IGC Pharma's growth, margins, and balance sheet.

Profit Margin shows how effectively IGC Pharma converts resources into returns. At -702.14%, IGC may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -477.92% in the prior-year period — down 46.9% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting IGC's profit margin (-702.14%), review year-over-year change from -477.92%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.